Fludarabine and treosulfan conditioning for allogeneic stem cell transplantation (SCT) in patients with AML and MDS not eligible for standard myeloablative conditioning: the role of treosulfan dose

被引：0
|
作者：
Shimoni, A. [1 ]
Peccatori, J. [2 ]
Shem-Tov, N. [1 ]
Lo Russo, A. [2 ]
Yerushalmi, R. [1 ]
Bernardi, M. [2 ]
Nagler, A. [1 ]
Ciceri, F. [2 ]
机构：
[1] Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel
[2] Ist Sci San Raffaele, I-20132 Milan, Italy
来源：
BONE MARROW TRANSPLANTATION | 2013年 / 48卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S220 / S220
页数：1
相关论文
共 50 条
  • [1] FLUDARABINE AND TREOSULFAN CONDITIONING FOR ALLOGENEIC STEM-CELL TRANSPLANTATION IN PATIENTS WITH AML AND MDS NOT ELIGIBLE FOR STANDARD MYELOABLATIVE CONDITIONING
    Shimoni, A.
    Crotta, A.
    Shem-Tov, N.
    Peccatori, J.
    Yerushalmi, R.
    Bernardi, M.
    Nagler, A.
    Ciceri, F.
    HAEMATOLOGICA, 2012, 97 : 177 - 177
  • [2] Allogeneic hematopoietic SCT in patients with AML following treosulfan/fludarabine conditioning
    J Casper
    J Holowiecki
    R Trenschel
    H Wandt
    K Schaefer-Eckart
    T Ruutu
    L Volin
    H Einsele
    G Stuhler
    L Uharek
    I Blau
    M Bornhaeuser
    A R Zander
    K Larsson
    M Markiewicz
    S Giebel
    T Kruzel
    H A Mylius
    J Baumgart
    U Pichlmeier
    M Freund
    D W Beelen
    Bone Marrow Transplantation, 2012, 47 : 1171 - 1177
  • [3] Allogeneic hematopoietic SCT in patients with AML following treosulfan/fludarabine conditioning
    Casper, J.
    Holowiecki, J.
    Trenschel, R.
    Wandt, H.
    Schaefer-Eckart, K.
    Ruutu, T.
    Volin, L.
    Einsele, H.
    Stuhler, G.
    Uharek, L.
    Blau, I.
    Bornhaeuser, M.
    Zander, A. R.
    Larsson, K.
    Markiewicz, M.
    Giebel, S.
    Kruzel, T.
    Mylius, H. A.
    Baumgart, J.
    Pichlmeier, U.
    Freund, M.
    Beelen, D. W.
    BONE MARROW TRANSPLANTATION, 2012, 47 (09) : 1171 - 1177
  • [4] Comparable outcomes for Fludarabine/TBI versus Fludarabine/Treosulfan conditioning prior to allogeneic stem cell transplantation (Allo-SCT) in AML and MDS patients
    Berning, P.
    Kolloch, L.
    Reicherts, C.
    Call, S.
    Marx, J.
    Floeth, M. P.
    Esseling, E.
    Schliemann, C.
    Lenz, G.
    Stelljes, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 140 - 140
  • [5] Allogeneic stem cell transplantation for lymphoma: role of conditioning with treosulfan and fludarabine
    Niittyvuopio, R.
    Heiskanen, J.
    Lindstrom, V.
    Juvonen, E.
    Nihtinen, A.
    Uotinen, H.
    Ruutu, T.
    Volin, L.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S426 - S427
  • [6] Treosulfan/fludarabine - a low toxicity but myeloablative conditioning for allogeneic hematopoietic stem cell transplantation
    Holowiecki, J
    Giebel, S
    Wojnar, J
    Krawczyk-Kulis, M
    Wylezol, I
    Kruzel, T
    Markiewicz, M
    BLOOD, 2004, 104 (11) : 292A - 292A
  • [7] Conditioning with treosulfan and fludarabine for allogeneic blood stem cell transplantation
    Casper, J
    Steiner, B
    Wolff, D
    Kleine, HD
    Wilhelm, S
    Hammer, U
    von Wurmb, N
    Roeber, S
    Wegener, R
    Freund, M
    BONE MARROW TRANSPLANTATION, 2001, 27 : S285 - S286
  • [8] Treosulfan in combination with fludarabine as conditioning for allogeneic stem cell transplantation in myelofibrosis
    Kragl, B.
    Heinz, F.
    Grosse-Thie, C.
    Henze, L.
    Lakner, J.
    Freitag, S.
    Wittke, C.
    Brueckner, F.
    Junghanss, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 151 - 152
  • [9] Comparable Survival for Fludarabine and Treosulfan Vs. Fludarabine and TBI As Conditioning Regimens in Patients with AML and MDS Undergoing Allogeneic Stem Cell Transplantation
    Kolloch, Lina
    Berning, Philipp
    Reicherts, Christian
    Call, Simon
    Marx, Julia
    Floeth, Matthias
    Esseling, Eva
    Ronnacker, Julian
    Mikesch, Jan-Henrik
    Schliemann, Christoph
    Lenz, Georg
    Stelljes, Matthias
    BLOOD, 2023, 142
  • [10] Allogeneic blood stem cell transplantation after treosulfan and fludarabine conditioning
    Casper, J
    Knauf, W
    Schwenke, M
    Steiner, B
    Wolff, D
    Lueck, A
    Leithaeuser, M
    Freund, M
    BONE MARROW TRANSPLANTATION, 2002, 29 : S152 - S152
12345